{
  "trial_id": "NCT01907334",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "parent/legal guardian and subject must be able to speak and understand English",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "patient must be willing and able to give assent to take part in the study",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "diagnosed with asthma for at least 6 months",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "able to demonstrate inhalation technique with study device",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "if taking inhaled corticosteroids, dose must be stable for 2 weeks",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "no significant concomitant medical conditions or abnormal physical findings on screening except for those consistent with asthma and allergic rhinitis",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "airway responsiveness to methacholine with a baseline provocational dose causing an increase of at least 40% in R5 (PC40R5) at no more than 8 mg/mL",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "female who has started menstruating",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "past or present history of any allergic reaction to any of the medications or formulations administered in this study",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "prior treatment with systemic corticosteroids in last 30 days or more than 4 courses in previous 12 months",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "use of short-acting beta-agonist more than two times per week in the previous month",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "use of long-acting beta-agonist in the 3 weeks before the first methacholine challenge or during the study",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "change in dosage of inhaled corticosteroids in previous 30 days, nasal steroids in previous 15 days and montelukast in last 7 days",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "history of life-threatening asthma, including loss of consciousness, intubation and/or admission to ICU",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "hospitalization for acute asthma within past year",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "The patient has a history of hypertension and hypercholesterolemia, but these conditions are not likely to affect his eligibility. He is on Levodopa and Trihexyphenidyl for Parkinson's disease, which may have some effect on his asthma symptoms, but this is not clear from the information provided.",
  "_meta": {
    "topic_id": "41",
    "trial_id": "NCT01907334",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}